BioSpace News Archive

There is an impressive amount of technological ingenuity – mRNA, monoclonal antibodies and more traditional formats – being thrown at the development of a vaccine against COVID-19.

Gastroesophageal pH meter refers to a direct in-vivo measurement that makes a measurement and keeps a record of the pH in esophagus for the purpose of evaluating gastroesophageal reflux disease or GERD.

The demand within the global OTC topical drugs market is slated to increase in the years to follow.

Face masks have become an essential non-pharmacological tool in combating the emerging COVID-19 pandemic.

For long, cardiovascular diseases have been spearheading gene testing and this trend is estimated to go on in the near future.

The growth of the global biodefense market can be evaluated by analysing the existing threats to the masses from various infectious diseases.

Company developing investigational treatment for both newly diagnosed patients and those with a more advanced form of the disease in need of adjunctive therapy

ICON plc, a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, announced that Mr. Brendan Brennan, CFO of ICON plc

Genmab A/S (Nasdaq: GMAB) and ADC Therapeutics SA (NYSE: ADCT) today announced that they have executed an amended agreement for ADC Therapeutics to continue the development and commercialization of camidanlumab tesirine (Cami).

Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that oliceridine has been classified as a Schedule II controlled substance by the U.S. Drug Enforcement Administration (DEA).